Teva Pharma Australia Key Therapeutic Areas
We provide medicines to improve health and enable better days, both prescription medications as well as over-the-counter treatments.
Teva is committed to delivering medicines to meet the needs of patients and families affected by disorders of the Central Nervous System (CNS).
A global leader in treatments for disorders of the central nervous system (CNS), Teva provides products to treat patients with neurological and neurodegenerative disorders, pain, and sleep disorders, in countries around the world.
Some of the more commonly known disorders within the CNS are Multiple Sclerosis (MS) 1, Parkinson’s disease and Alzheimer’s disease.
Teva is also developing innovative solutions in headache and migraine, and socially responsible pain treatments.
Teva is committed to providing high-quality treatments for people who suffer from respiratory diseases, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD). Our innovative approach to respiratory care is centered on optimizing therapies through novel delivery systems and medicines that are designed to address patient needs.
Teva is focused on developing and providing treatment options that address two major issues within the current treatment landscape for respiratory diseases: 1) treatment adherence and compliance and 2) treating asthma that remains uncontrolled despite the use of a standard of care therapy.
In the treatment of asthma, the goal is to maintain asthma control so people with asthma can maintain good lung function, exhibit fewer symptoms and experience fewer asthma exacerbations.
In addition to our currently available medicines, Teva has a broad pipeline of treatment options currently in development with the goal of further enhancing our product offerings and addressing unmet needs within the respiratory community.
With over 100 years of global pharmaceutical expertise, our mission is to provide solutions in advanced cancer care and improve the lives of people affected by cancer.
Cancer treatment is often associated with side effects of the chemotherapy like neutropenia, where the number of infection-fighting white blood cells is reduced as a result of chemotherapy.
We offer a range of products that help healthcare professionals to respond effectively to the individual requirements of each patient.
Teva’s over-the-counter (OTC) products include a range of consumer healthcare treatments available without a prescription that help to heal, relieve and prevent a variety of conditions. Our portfolio also features well-known brands such as Sudocrem®, Infacol® and Hairy Lemon®
Our experience in markets with significantly different customer cultures and needs gives us the agility for timely delivery of the relevant products and quantities. With a global presence, timely, reliable and cost-effective distribution is critical to our customers’ ability to provide their end consumers with safe and effective products at the right time.
Back to contents.
within the CNS area